A G-CSF receptor-gyrase B fusion gene: A new type of molecular switch for expansion of genetically modified hematopoietic cells

Biochem Biophys Res Commun. 1999 Jun 24;260(1):9-12. doi: 10.1006/bbrc.1999.0859.

Abstract

We have developed a novel system for expansion of transduced hematopoietic cells. This system involves "selective amplifier genes" encoding fusion proteins between the granulocyte colony-stimulating factor receptor (Gcr) and the estrogen receptor (Er). The GcrEr chimeric gene conferred estrogen-dependent growth ability on murine hematopoietic cells. Here, we constructed a modified "selective amplifier gene" to circumvent possible concerns with the Er/estrogen switching system. The bacterial gyrase B (Gyr) gene was fused to the Gcr gene, and the GcrGyr fusion construct was introduced into interleukin-3 (IL-3)-dependent Ba/F3 cells. The dimeric antibiotic coumermycin induced IL-3-independent growth in Ba/F3 cells expressing GcrGyr. This stimulatory effect was antagonized by an excess amount of novobiocin, a monomeric form of coumermycin. These results suggest the feasibility of using Gyr as a molecular switch to regulate a growth signal in hematopoietic cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminocoumarins
  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Artificial Gene Fusion
  • Cell Count
  • Cell Culture Techniques
  • Cell Line
  • Chimera
  • Coumarins / pharmacology
  • DNA Gyrase
  • DNA Topoisomerases, Type II / genetics*
  • Gene Expression Regulation*
  • Hematopoietic Stem Cells / metabolism*
  • Mice
  • Novobiocin / pharmacology
  • Receptors, Granulocyte Colony-Stimulating Factor / genetics*
  • Time Factors
  • Transfection

Substances

  • Aminocoumarins
  • Anti-Bacterial Agents
  • Coumarins
  • Receptors, Granulocyte Colony-Stimulating Factor
  • Novobiocin
  • DNA Gyrase
  • DNA Topoisomerases, Type II
  • coumermycin